Skip to main content
JUNS
NASDAQ Life Sciences

Jupiter Neurosciences Raises $2M at $6.50/Share, Aims to Regain Nasdaq Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$5.37
Mkt Cap
$4.359M
52W Low
$4.56
52W High
$137.963
52W Position info
18% above low
Off High info
96% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

JUNS sits 18% above its 52-week low of $4.56.

Summary

Jupiter Neurosciences raised $2.0 million via a registered direct offering at $6.50 per share and believes it has regained Nasdaq's minimum stockholders' equity requirement, pending formal confirmation.


Key Events · Financing and Capital Events · JUNS

  • Registered Direct Offering Closed

    Issued and sold 307,692 shares at $6.50 per share for approximately $2.0 million in gross proceeds before placement agent fees and expenses.

  • Nasdaq Compliance Update

    Company believes stockholders' equity now exceeds the $2.5 million Nasdaq minimum, but is awaiting formal Nasdaq determination and acknowledges continued monitoring.

  • Delisting Risk Remains

    If the next periodic report does not evidence compliance, securities may be subject to delisting.


Analysis · JUNS · Life Sciences

A registered direct offering of 307,692 shares at $6.50 per share has closed, generating approximately $2.0 million in gross proceeds. The company now believes stockholders' equity exceeds the $2.5 million Nasdaq minimum, addressing a delisting risk that has been a recurring concern. However, Nasdaq has not yet formally confirmed compliance, and the company acknowledges continued monitoring and potential delisting if future periodic reports fail to evidence compliance.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, JUNS was trading at $5.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4M. The 52-week trading range was $4.56 to $137.96. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JUNS - Latest Insights

JUNS
Aug 28, 2026, 6:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $3.38
Real-time Price: $3.45 info
Change: +$0.070 (+2%) info
Market Cap: $4.549M info
JUNS
Aug 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.12
Real-time Price: $3.45 info
Change: -$0.6724 (-16%) info
Market Cap: $4.549M info
JUNS
Aug 24, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.38
Real-time Price: $3.45 info
Change: -$1.93 (-36%) info
Market Cap: $4.549M info
JUNS
Aug 24, 2026, 8:00 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $5.41
Real-time Price: $3.45 info
Change: -$1.96 (-36%) info
Market Cap: $4.549M info
JUNS
Aug 14, 2026, 4:40 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.30
Real-time Price: $3.45 info
Change: -$1.85 (-35%) info
Market Cap: $4.549M info